Avid Bioservices, Inc. - Common Stock (CDMO)

Competitors to Avid Bioservices, Inc. - Common Stock (CDMO)

Catalent, Inc. 

Catalent, Inc. competes with Avid Bioservices by offering comprehensive solutions for drug development, delivery, and manufacturing. Catalent has a robust global footprint and leverages advanced technologies, such as gene and cell therapies, positioning itself as a frontrunner in the market. Their established relationships with major pharmaceutical companies, combined with their breadth of services and enhanced operational efficiencies, give them a notable competitive advantage over Avid in securing high-profile contracts and innovation in drug manufacturing.

DSM Bio-based Products

DSM Bio-based Products competes with Avid Bioservices in the biologics and biopharmaceuticals manufacturing sector by focusing on sustainability and efficiency in production methods. With an increasing market demand for sustainable practices in drug manufacturing, DSM emphasizes its bio-based technologies and environmentally friendly production processes as a competitive edge. While Avid Bioservices specializes in specific bioprocessing capabilities, DSM's strong commitment to sustainability may attract clients prioritizing eco-friendly practices, creating differentiated competition.

Lonza Group AG

Lonza Group AG is a leading global player in the biopharmaceutical and biologics manufacturing domain, competing directly with Avid Bioservices by offering contract development and manufacturing services. Lonza's extensive infrastructure and technological advancements provide it with a significant edge in large-scale biopharmaceutical production. They have also established a strong reputation for quality and reliability, which can attract larger clients and more complex projects compared to Avid, giving Lonza a competitive advantage in terms of market reach and service capabilities.

Praxair Technology, Inc.

While primarily known for gas distribution, Praxair Technology, Inc. is involved in the biopharmaceutical supply chain, competing indirectly with Avid Bioservices by offering essential services like manufacturing gases used in biopharmaceutical production. Their specialization in process optimization and cost reduction through enhanced gas supply solutions can provide biomanufacturers higher efficiency and effectiveness. However, Avid's focus on biologics production gives it a more tailored approach to meet specific client needs in drug development, making it less direct as a competitor.

Sartorius AG

Sartorius AG competes with Avid Bioservices in the biopharmaceutical contract development and manufacturing space, offering a wide range of solutions including equipment and consumables for bioprocessing. Sartorius leverages its strong presence in the global market and extensive product portfolio to provide integrated solutions that appeal to a diverse range of biopharmaceutical developers. With substantial investments in technology and R&D, Sartorius maintains a competitive advantage in innovation and scalability, which allows them to serve clients with varying degrees of complexity in their development processes.